Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.04
-0.13
(-5.99%)
USD |
NASDAQ |
Nov 06, 16:00
2.08
+0.04
(+1.96%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Total Long Term Debt (Quarterly) : 1.96M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.96M |
| March 31, 2026 | 2.106M |
| December 31, 2025 | 2.244M |
| September 30, 2025 | 2.381M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 0.984M |
| IRulya Therapeutics, Inc. | 0.00 |
| PepGen Inc. | 12.86M |
| Q32 Bio, Inc. | 4.364M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |